IL98911A0 - 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them - Google Patents
2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing themInfo
- Publication number
- IL98911A0 IL98911A0 IL98911A IL9891191A IL98911A0 IL 98911 A0 IL98911 A0 IL 98911A0 IL 98911 A IL98911 A IL 98911A IL 9891191 A IL9891191 A IL 9891191A IL 98911 A0 IL98911 A0 IL 98911A0
- Authority
- IL
- Israel
- Prior art keywords
- fluorenonyl
- carbapenems
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/561,547 US5034384A (en) | 1990-08-01 | 1990-08-01 | 2-(9-fluorenonyl)-carbapenem antibacterial agents |
| US59480890A | 1990-10-09 | 1990-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL98911A0 true IL98911A0 (en) | 1992-07-15 |
Family
ID=27072675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL98911A IL98911A0 (en) | 1990-08-01 | 1991-07-22 | 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0472306A1 (de) |
| JP (1) | JP2509771B2 (de) |
| KR (1) | KR920004388A (de) |
| CA (1) | CA2048269A1 (de) |
| FI (1) | FI913655A (de) |
| IE (1) | IE912709A1 (de) |
| IL (1) | IL98911A0 (de) |
| MX (1) | MX9100466A (de) |
| NO (1) | NO912980L (de) |
| NZ (1) | NZ239186A (de) |
| PT (1) | PT98522A (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5451579A (en) * | 1994-02-15 | 1995-09-19 | Merck & Co., Inc. | 1-β-methyl-carbapenem, compositions containing same and methods of use |
| US5756725A (en) * | 1996-04-24 | 1998-05-26 | Merck & Co., Inc. | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| JP2001500862A (ja) * | 1996-09-12 | 2001-01-23 | メルク エンド カンパニー インコーポレーテッド | カルバペネム系抗菌化合物、該化合物を含む組成物および治療方法 |
| KR20020036905A (ko) * | 2000-11-11 | 2002-05-17 | 황영헌 | 비정상 상태 제어장치 및 방법과 그 프로그램 소스를저장한 기록매체 |
| AU2011276157B2 (en) | 2010-07-08 | 2016-12-22 | Hans Rudolf Pfaendler | Fluorescent carbapenems |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4543257A (en) * | 1977-10-19 | 1985-09-24 | Merck & Co., Inc. | 1-Carba-2-penem-3-carboxylic acid |
| US4260627A (en) * | 1978-10-24 | 1981-04-07 | Merck & Co., Inc. | 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids |
| US4600713A (en) * | 1979-12-03 | 1986-07-15 | Merck & Co., Inc. | 1-, 6- and 2-substituted-1-carba-2-penem-3-carboxylic acids |
| EP0277743A1 (de) * | 1987-02-02 | 1988-08-10 | Merck & Co. Inc. | 2-(Heteroaryliumalkyl)phenyl-carbapeneme als antibakterielle Mittel |
-
1991
- 1991-07-22 IL IL98911A patent/IL98911A0/xx unknown
- 1991-07-30 EP EP91306955A patent/EP0472306A1/de not_active Ceased
- 1991-07-30 NZ NZ239186A patent/NZ239186A/xx unknown
- 1991-07-31 KR KR1019910013161A patent/KR920004388A/ko not_active Application Discontinuation
- 1991-07-31 PT PT98522A patent/PT98522A/pt not_active Application Discontinuation
- 1991-07-31 IE IE270991A patent/IE912709A1/en unknown
- 1991-07-31 FI FI913655A patent/FI913655A/fi not_active Application Discontinuation
- 1991-07-31 MX MX9100466A patent/MX9100466A/es not_active IP Right Cessation
- 1991-07-31 JP JP3280913A patent/JP2509771B2/ja not_active Expired - Lifetime
- 1991-07-31 NO NO91912980A patent/NO912980L/no unknown
- 1991-08-01 CA CA002048269A patent/CA2048269A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT98522A (pt) | 1992-06-30 |
| JP2509771B2 (ja) | 1996-06-26 |
| AU8151791A (en) | 1992-02-06 |
| JPH05105679A (ja) | 1993-04-27 |
| FI913655A0 (fi) | 1991-07-31 |
| NZ239186A (en) | 1993-12-23 |
| NO912980D0 (no) | 1991-07-31 |
| NO912980L (no) | 1992-02-03 |
| KR920004388A (ko) | 1992-03-27 |
| CA2048269A1 (en) | 1992-02-02 |
| IE912709A1 (en) | 1992-02-12 |
| AU642518B2 (en) | 1993-10-21 |
| MX9100466A (es) | 1992-04-01 |
| EP0472306A1 (de) | 1992-02-26 |
| FI913655A (fi) | 1992-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2251791B (en) | Pharmaceutical compositions containing benzenesulphonamides | |
| NZ244766A (en) | Bi-aromatic compounds and pharmaceutical compositions | |
| IL97122A0 (en) | Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them | |
| GB9115893D0 (en) | Pharmaceutical compositions | |
| GB9011767D0 (en) | Pharmaceutical compositions | |
| GB9023023D0 (en) | Pharmaceutical compositions | |
| NZ239483A (en) | Phosphonopyrrolidine or -piperidine derivatives and pharmaceutical compositions | |
| ZA911065B (en) | Chemical and pharmaceutical compositions | |
| IL98911A0 (en) | 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them | |
| IL99011A0 (en) | 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them | |
| GB9026080D0 (en) | Pharmaceutical compositions | |
| IL104120A0 (en) | Novel thiazoles and pharmaceutical compositions containing them | |
| GB9003185D0 (en) | Pharmaceutical compositions | |
| GB9015435D0 (en) | Pharmaceutical compositions | |
| ZA915450B (en) | Pharmaceutical composition | |
| IL94658A0 (en) | 1,5-diazabicyclodiones and pharmaceutical compositions containing them | |
| GB9115169D0 (en) | Pharmaceutical compositions | |
| IL93286A0 (en) | Pharmaceutical compositions comprising arylalkyl-amines and-amides and certain such novel compounds | |
| HU9803012D0 (en) | N-cycloalkyl-amine-derivatives and pharmaceutical compositions containing the same | |
| GB9005599D0 (en) | Pharmaceutical composition | |
| GB9015988D0 (en) | Pharmaceutical composition | |
| GB9023953D0 (en) | Pharmaceutical composition | |
| ZA918388B (en) | Pharmaceutical composition | |
| IE901558L (en) | Pharmaceutical composition | |
| ZA911438B (en) | Pharmaceutical composition |